Aurora Cannabis Buying Late-Stage ACMPR Applicant Peloton Pharmaceuticals

Visit the Aurora Cannabis Investor Dashboard and stay up to date with data-driven, fact based due diligence for active traders and investors.

Aurora Cannabis Inc. (CNW Group/Aurora Cannabis Inc.)

Aurora to Acquire Peloton Pharmaceuticals Inc.

VANCOUVER, March 6, 2017 /CNW/ – Aurora Cannabis Inc. (the “Company” or “Aurora”) (TSXV: ACB) (OTC: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) is pleased to announce that its proposal (the “Proposal”) to acquire Peloton Pharmaceuticals Inc. (“Peloton”), a late-stage ACMPR-applicant, out of bankruptcy protection was approved by Peloton’s creditors at a recent meeting (the “Creditor Meeting”).

Peloton is constructing a 40,000 square foot cannabis production facility in Pointe Claire, Quebec, which received a “ready to build” letter from Health Canada in 2014. The Company estimates that construction of the Peloton facility is 80% complete, and expects to be ready for Health Canada inspection pursuant to a License to Produce by the summer of 2017.

Under the terms of the Proposal, and subject to all conditions precedent being satisfied, the Company will provide a total investment pool of $7,000,000 of cash and common shares of Aurora for distribution to creditors.

Completion of the acquisition of Peloton is conditional upon, among other things, the Proposal being approved by the Quebec Superior Court of Justice (the “Court”) and TSX Venture Exchange approval.

The motion to approve the Proposal is scheduled to be heard by the Court in late March. Although the motion may be contested by certain minority shareholders of Peloton, the Company anticipates that the Court will grant approval for the Proposal. The Proposal was approved by the required majority of Peloton’s creditors at the Creditor Meeting, with no creditors voting against it, and is being supported by Peloton’s current management.

About Aurora

Aurora’s wholly-owned subsidiary, Aurora Cannabis Enterprises Inc., is a licensed producer of medical cannabis pursuant to Health Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR). The Company operates a 55,200 square foot, state-of-the-art production facility in Mountain View County, Alberta, and is currently constructing a second 800,000 square foot production facility, known as “Aurora Sky”, at the Edmonton International Airport. The Aurora Sky project has secured advanced technology from the most renowned design and construction suppliers in the Netherlands. Aurora’s common shares trade on the TSX-V under the symbol “ACB”.

Original press release: http://www.newswire.ca/news-releases/aurora-to-acquire-peloton-pharmaceuticals-inc-615496183.html

For fact-based information on Aurora Cannabis, view the company’s sponsored Investor Dashboard.

Get ahead of the crowd by signing up for 420 Investor, the largest & most comprehensive premium subscription service for cannabis traders and investors since 2013.

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.

Get Our Sunday Newsletter